Stemtech Corporation (STEK)

Market Cap	337.07K -94.0%
Revenue (ttm)	3.73M -26.8%
Net Income	-2.96M
EPS	-0.02
Shares Out	1.12B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	16,512,272
Open	0.0003
Previous Close	0.0003
Day's Range	0.0003 - 0.0003
52-Week Range	0.0002 - 0.0420
Beta	2.31
RSI	39.91
Earnings Date	May 11, 2026

About Stemtech

Stemtech Corporation, a stem cell nutrition company, develops science-based products to help the body maintain healthy stem cell physiology in the Americas, Latin America, and Asia. The company’s products enhance and support the work of the body’s stem cells by releasing more stem cells, helping to circulate them in the blood, and migrate them into tissues, where they can perform their daily function of renewal for optimal health. It offers rapid renew stem cell peptide night cream under the RCM System, stemrelease3, Stemflo MigraStem, OraStem,...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2005
• Employees: 80
• Stock Exchange: OTCMKTS
• Ticker Symbol: STEK

Financial Performance

In 2024, Stemtech's revenue was $5.05 million, an increase of 2.69% compared to the previous year's $4.92 million. Losses were -$3.77 million, -30.58% less than in 2023.